US7888466B2
(en)
|
1996-01-11 |
2011-02-15 |
Human Genome Sciences, Inc. |
Human G-protein chemokine receptor HSATU68
|
US7357927B2
(en)
|
1996-03-12 |
2008-04-15 |
Human Genome Sciences, Inc. |
Death domain containing receptors
|
WO1997033904A1
(en)
|
1996-03-12 |
1997-09-18 |
Human Genome Sciences, Inc. |
Death domain containing receptors
|
US6713061B1
(en)
|
1996-03-12 |
2004-03-30 |
Human Genome Sciences, Inc. |
Death domain containing receptors
|
US6635743B1
(en)
|
1996-03-22 |
2003-10-21 |
Human Genome Sciences, Inc. |
Apoptosis inducing molecule II and methods of use
|
US7964190B2
(en)
|
1996-03-22 |
2011-06-21 |
Human Genome Sciences, Inc. |
Methods and compositions for decreasing T-cell activity
|
US6455040B1
(en)
|
1997-01-14 |
2002-09-24 |
Human Genome Sciences, Inc. |
Tumor necrosis factor receptor 5
|
EP0857782A3
(de)
*
|
1997-01-27 |
1999-12-22 |
Smithkline Beecham Corporation |
Säugetiergen DD-1
|
US8329179B2
(en)
|
1997-01-28 |
2012-12-11 |
Human Genome Sciences, Inc. |
Death domain containing receptor 4 antibodies and methods
|
US6433147B1
(en)
|
1997-01-28 |
2002-08-13 |
Human Genome Sciences, Inc. |
Death domain containing receptor-4
|
US7452538B2
(en)
|
1997-01-28 |
2008-11-18 |
Human Genome Sciences, Inc. |
Death domain containing receptor 4 antibodies and methods
|
US6342363B1
(en)
*
|
1997-01-28 |
2002-01-29 |
Human Genome Sciences, Inc. |
Death domain containing receptor 4 nucleic acids and methods
|
US7528239B1
(en)
*
|
1997-02-13 |
2009-05-05 |
Immunex Corporation |
Receptor that binds trail
|
US6072047A
(en)
|
1997-02-13 |
2000-06-06 |
Immunex Corporation |
Receptor that binds trail
|
US20040136951A1
(en)
*
|
1997-03-17 |
2004-07-15 |
Human Genome Sciences, Inc. |
Death domain containing receptor 5
|
US20050233958A1
(en)
*
|
1997-03-17 |
2005-10-20 |
Human Genome Sciences, Inc. |
Death domain containing receptor 5
|
US20080248046A1
(en)
*
|
1997-03-17 |
2008-10-09 |
Human Genome Sciences, Inc. |
Death domain containing receptor 5
|
AU747635B2
(en)
*
|
1997-03-17 |
2002-05-16 |
Human Genome Sciences, Inc. |
Death domain containing receptor 5
|
US6872568B1
(en)
*
|
1997-03-17 |
2005-03-29 |
Human Genome Sciences, Inc. |
Death domain containing receptor 5 antibodies
|
US6506569B1
(en)
|
1997-05-30 |
2003-01-14 |
Human Genome Sciences, Inc. |
Antibodies to human tumor necrosis factor receptor TR10
|
WO1998054202A1
(en)
*
|
1997-05-30 |
1998-12-03 |
Human Genome Sciences, Inc. |
Human tumor necrosis factor receptor tr10
|
JP4303883B2
(ja)
|
1997-09-18 |
2009-07-29 |
ジェネンテック・インコーポレーテッド |
DcR3ポリペプチドというTNFR相同体
|
US20040120947A1
(en)
*
|
1998-01-26 |
2004-06-24 |
Genentech, Inc. |
DR4 antibodies and uses thereof
|
AU2007200507B2
(en)
*
|
1998-01-26 |
2010-03-11 |
Genentech, Inc. |
Antibodies to death receptor 4 (DR4) and uses thereof
|
IL137176A0
(en)
|
1998-01-26 |
2001-07-24 |
Genentech Inc |
Antibodies to 4dr and uses thereof
|
US20040180049A1
(en)
*
|
1998-01-26 |
2004-09-16 |
Genentech, Inc. |
DR4 antibodies and uses thereof
|
US20050281821A1
(en)
*
|
1999-01-06 |
2005-12-22 |
Flavia Pernasetti |
Method and composition for angiogenesis inhibition
|
CA2363779A1
(en)
|
1999-02-26 |
2000-08-31 |
Human Genome Sciences, Inc. |
Human endokine alpha and methods of use
|
CA2371114A1
(en)
*
|
1999-04-22 |
2000-11-02 |
Human Genome Sciences, Inc. |
Death domain containing receptors
|
EP1178828A4
(de)
*
|
1999-05-06 |
2004-10-13 |
Human Genome Sciences Inc |
"death-domain"enthaltender rezeptor
|
EP1181319B1
(de)
*
|
1999-05-28 |
2009-04-22 |
Genentech, Inc. |
Chimärische dr4 antikörper und ihre verwendung
|
EP1212413A1
(de)
*
|
1999-08-25 |
2002-06-12 |
Genome Therapeutics Corporation |
Eine transmembranfalle zur isolierung von membrangebundenen proteinen
|
DK1255558T3
(da)
|
2000-02-16 |
2006-10-23 |
Genentech Inc |
Anti-april antistoffer og hybridomaceller
|
BR0110610A
(pt)
|
2000-04-11 |
2003-04-29 |
Genentech Inc |
Anticorpos isolados, imunoconjugados, cadeias de polipeptìdeos, ácido nucléico isolado, vetor, célula hospedeira, processo de produção de anticorpo ou cadeia de polipeptìdeos, método de tratamento de disfunções em mamìferos, método de indução da apoptose de uma célula cancerosa, método para matar uma célula b, método para matar uma célula que expresse um receptor de erbb e usos dos anticorpos isolados
|
EP1274720A4
(de)
|
2000-04-12 |
2004-08-18 |
Human Genome Sciences Inc |
Albumin enthaltende fusionsproteine
|
US7476383B2
(en)
*
|
2000-05-02 |
2009-01-13 |
The Uab Research Foundation |
Antibody selective for DR4 and uses thereof
|
US7279160B2
(en)
|
2000-05-02 |
2007-10-09 |
The Uab Research Foundation |
Combinations of DR5 antibodies and other therapeutic agents
|
TWI318983B
(en)
|
2000-05-02 |
2010-01-01 |
Uab Research Foundation |
An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
|
EP1294949A4
(de)
|
2000-06-15 |
2004-08-25 |
Human Genome Sciences Inc |
Menschlicher tumornekrosefaktor delta und epsilon
|
ATE494304T1
(de)
|
2000-06-16 |
2011-01-15 |
Human Genome Sciences Inc |
Immunspezifisch bindende antikörper gegen blys
|
CA2415473A1
(en)
*
|
2000-07-27 |
2002-02-07 |
Genentech, Inc. |
Apo-2l receptor agonist and cpt-11 synergism
|
US20060062786A1
(en)
*
|
2000-11-08 |
2006-03-23 |
Human Genome Sciences, Inc. |
Antibodies that immunospecifically bind to TRAIL receptors
|
US20030228309A1
(en)
*
|
2000-11-08 |
2003-12-11 |
Theodora Salcedo |
Antibodies that immunospecifically bind to TRAIL receptors
|
AU2001297702A1
(en)
*
|
2000-11-08 |
2002-10-15 |
Human Genome Sciences, Inc. |
Antibodies that immunospecifically bind to trail receptors
|
US20020155109A1
(en)
*
|
2001-04-20 |
2002-10-24 |
Lynch David H. |
Bispecific antibodies that bind TRAIL-R1 and TRAIL-R2
|
WO2002094880A1
(en)
*
|
2001-05-18 |
2002-11-28 |
Kirin Beer Kabushiki Kaisha |
Anti-trail-r antibodies
|
US20050214209A1
(en)
*
|
2001-05-25 |
2005-09-29 |
Human Genome Sciences, Inc. |
Antibodies that immunospecifically bind to TRAIL receptors
|
US7361341B2
(en)
*
|
2001-05-25 |
2008-04-22 |
Human Genome Sciences, Inc. |
Methods of treating cancer using antibodies that immunospecifically bind to trail receptors
|
US20090226429A1
(en)
*
|
2001-05-25 |
2009-09-10 |
Human Genome Sciences, Inc. |
Antibodies That Immunospecifically Bind to TRAIL Receptors
|
US20050129616A1
(en)
*
|
2001-05-25 |
2005-06-16 |
Human Genome Sciences, Inc. |
Antibodies that immunospecifically bind to TRAIL receptors
|
US7348003B2
(en)
|
2001-05-25 |
2008-03-25 |
Human Genome Sciences, Inc. |
Methods of treating cancer using antibodies that immunospecifically bind to TRAIL receptors
|
JP4309758B2
(ja)
|
2001-05-25 |
2009-08-05 |
ヒューマン ジノーム サイエンシーズ, インコーポレイテッド |
Trailレセプターに免疫特異的に結合する抗体
|
EP1409544B1
(de)
|
2001-07-03 |
2009-06-17 |
Genentech, Inc. |
Humane dr4-antikörper und deren anwendungen
|
WO2003013584A1
(en)
*
|
2001-08-09 |
2003-02-20 |
Genset S.A. |
Xafinix agonists and antagonists for use in the treatment of metabolic disorders
|
ES2357225T3
(es)
*
|
2001-11-01 |
2011-04-20 |
Uab Research Foundation |
Combinaciones de anticuerpos anti-dr5 y anticuerpos anti-dr4 y otros agentes terapéuticos.
|
US7842668B1
(en)
|
2001-11-13 |
2010-11-30 |
Genentech, Inc. |
Apo-2 ligand/trail formulations
|
CA2466054C
(en)
|
2001-11-13 |
2012-01-03 |
Genentech, Inc. |
Apo-2 ligand/trail formulations
|
US7741285B2
(en)
|
2001-11-13 |
2010-06-22 |
Genentech, Inc. |
APO-2 ligand/trail formulations
|
KR20040070254A
(ko)
*
|
2001-12-20 |
2004-08-06 |
휴먼 게놈 사이언시즈, 인코포레이티드 |
Trail 수용체에 면역특이적으로 결합하는 항체
|
EP2277888A3
(de)
|
2001-12-21 |
2011-04-27 |
Human Genome Sciences, Inc. |
Fusionsprotein von Albumin und Erythropoietin
|
WO2003104395A2
(en)
*
|
2002-05-22 |
2003-12-18 |
Incyte Corporation |
Receptors and membrane-associated proteins
|
JP4574350B2
(ja)
|
2002-06-24 |
2010-11-04 |
ジェネンテック, インコーポレイテッド |
Apo−2リガンド/trail変異体とその使用法
|
US7902338B2
(en)
|
2003-07-31 |
2011-03-08 |
Immunomedics, Inc. |
Anti-CD19 antibodies
|
AU2004285412A1
(en)
|
2003-09-12 |
2005-05-12 |
Minnow Medical, Llc |
Selectable eccentric remodeling and/or ablation of atherosclerotic material
|
JP2007513611A
(ja)
*
|
2003-11-26 |
2007-05-31 |
ザ クイーンズ ユニヴァーシティ オブ ベルファスト |
癌治療
|
US7892539B2
(en)
*
|
2004-03-24 |
2011-02-22 |
The Regents Of The University Of California |
Modulation of an innate immune response by altering TRIAL-R signaling
|
US20080260763A1
(en)
*
|
2004-07-01 |
2008-10-23 |
The Regents Of The University Of California |
High Throughput Proteomics
|
ES2365719T3
(es)
|
2004-08-06 |
2011-10-10 |
Genentech, Inc. |
Ensayos y procedimientos que utilizan biomarcadores.
|
ZA200701657B
(en)
|
2004-08-06 |
2008-09-25 |
Genentech Inc |
Assays and methods using biomarkers
|
RU2007112952A
(ru)
*
|
2004-09-08 |
2008-10-20 |
Дженентек, Инк. (Us) |
Способы применения лигандов рецепторов смерти и cd20-антител
|
MX2007002855A
(es)
*
|
2004-09-08 |
2007-04-27 |
Genentech Inc |
Metodos para usar ligandos de receptor de muerte y anticuerpos cd20.
|
US9713730B2
(en)
|
2004-09-10 |
2017-07-25 |
Boston Scientific Scimed, Inc. |
Apparatus and method for treatment of in-stent restenosis
|
US8396548B2
(en)
|
2008-11-14 |
2013-03-12 |
Vessix Vascular, Inc. |
Selective drug delivery in a lumen
|
US9277955B2
(en)
|
2010-04-09 |
2016-03-08 |
Vessix Vascular, Inc. |
Power generating and control apparatus for the treatment of tissue
|
JO3000B1
(ar)
*
|
2004-10-20 |
2016-09-05 |
Genentech Inc |
مركبات أجسام مضادة .
|
US8029783B2
(en)
|
2005-02-02 |
2011-10-04 |
Genentech, Inc. |
DR5 antibodies and articles of manufacture containing same
|
AU2006210838B2
(en)
|
2005-02-02 |
2011-10-20 |
The Uab Research Foundation |
Agents and methods related to reducing resistance to apoptosis-inducing death receptor agonists
|
US20090155247A1
(en)
*
|
2005-02-18 |
2009-06-18 |
Ashkenazi Avi J |
Methods of Using Death Receptor Agonists and EGFR Inhibitors
|
ZA200800969B
(en)
*
|
2005-08-16 |
2009-08-26 |
Genentech Inc |
Apoptosis sensitivity to APO2L/TRAIL by testing for GalNac-T14 expression in cells/tissues
|
WO2007024921A2
(en)
*
|
2005-08-24 |
2007-03-01 |
Cell Matrix |
Combination therapies for inhibiting integrin-extracellular matrix interactions
|
PE20071101A1
(es)
*
|
2005-08-31 |
2007-12-21 |
Amgen Inc |
Polipeptidos y anticuerpos
|
NZ568204A
(en)
|
2005-10-13 |
2012-01-12 |
Human Genome Sciences Inc |
Methods and compositions for use in treatment of patients with autoantibody positive diseases
|
ES2618543T3
(es)
|
2005-11-23 |
2017-06-21 |
Genentech, Inc. |
Métodos y composiciones relacionados con ensayos de linfocitos B
|
US8019435B2
(en)
|
2006-05-02 |
2011-09-13 |
Boston Scientific Scimed, Inc. |
Control of arterial smooth muscle tone
|
EP2455034B1
(de)
|
2006-10-18 |
2017-07-19 |
Vessix Vascular, Inc. |
System zur Herbeiführung gewünschter Temperatureffekte auf Körpergewebe
|
CA2666661C
(en)
|
2006-10-18 |
2015-01-20 |
Minnow Medical, Inc. |
Tuned rf energy and electrical tissue characterization for selective treatment of target tissues
|
JP5479901B2
(ja)
|
2006-10-18 |
2014-04-23 |
べシックス・バスキュラー・インコーポレイテッド |
身体組織に対する所望の温度作用の誘発
|
US9297803B2
(en)
*
|
2006-11-01 |
2016-03-29 |
Immport Therapeutics, Inc. |
Compositions and methods for immunodominant antigens
|
US8642067B2
(en)
|
2007-04-02 |
2014-02-04 |
Allergen, Inc. |
Methods and compositions for intraocular administration to treat ocular conditions
|
CN102014937A
(zh)
|
2008-03-03 |
2011-04-13 |
迈阿密大学 |
基于异基因癌细胞的免疫治疗
|
WO2010045002A2
(en)
|
2008-09-26 |
2010-04-22 |
Tocagen Inc. |
Gene therapy vectors and cytosine deaminases
|
US20100105620A1
(en)
*
|
2008-10-10 |
2010-04-29 |
Anaphore, Inc. |
Polypeptides that bind Trail-R1 and Trail-R2
|
CN102271603A
(zh)
|
2008-11-17 |
2011-12-07 |
明诺医学股份有限公司 |
得知或未得知组织形态的选择性能量积累
|
EP3939617A1
(de)
|
2009-02-13 |
2022-01-19 |
Immunomedics, Inc. |
Konjugate mit einer intrazellulär spaltbaren bindung
|
CA2774260C
(en)
|
2009-09-16 |
2018-10-09 |
Immunomedics, Inc. |
Class i anti-cea antibodies and uses thereof
|
US20110086770A1
(en)
*
|
2009-10-09 |
2011-04-14 |
Anaphore, Inc. |
Combinatorial Libraries Based on C-type Lectin-like Domain
|
KR20120101050A
(ko)
|
2009-11-05 |
2012-09-12 |
더 유에이비 리서치 파운데이션 |
기저형 유전자형 암의 치료 방법
|
IN2012DN03354A
(de)
|
2009-12-02 |
2015-10-23 |
Immunomedics Inc |
|
US8703712B2
(en)
|
2010-03-18 |
2014-04-22 |
The Uab Research Foundation |
Targeting cancer stem cells with DR5 agonists
|
US9192790B2
(en)
|
2010-04-14 |
2015-11-24 |
Boston Scientific Scimed, Inc. |
Focused ultrasonic renal denervation
|
AU2011252841B2
(en)
|
2010-05-14 |
2014-04-03 |
Amgen Inc. |
Enhanced death receptor agonists
|
US8473067B2
(en)
|
2010-06-11 |
2013-06-25 |
Boston Scientific Scimed, Inc. |
Renal denervation and stimulation employing wireless vascular energy transfer arrangement
|
EP2582725A4
(de)
*
|
2010-06-16 |
2014-05-07 |
Us Gov Health & Human Serv |
Anti-dr4-agonisten-antikörper
|
US9155589B2
(en)
|
2010-07-30 |
2015-10-13 |
Boston Scientific Scimed, Inc. |
Sequential activation RF electrode set for renal nerve ablation
|
US9408661B2
(en)
|
2010-07-30 |
2016-08-09 |
Patrick A. Haverkost |
RF electrodes on multiple flexible wires for renal nerve ablation
|
US9463062B2
(en)
|
2010-07-30 |
2016-10-11 |
Boston Scientific Scimed, Inc. |
Cooled conductive balloon RF catheter for renal nerve ablation
|
US9358365B2
(en)
|
2010-07-30 |
2016-06-07 |
Boston Scientific Scimed, Inc. |
Precision electrode movement control for renal nerve ablation
|
US9084609B2
(en)
|
2010-07-30 |
2015-07-21 |
Boston Scientific Scime, Inc. |
Spiral balloon catheter for renal nerve ablation
|
US9725689B2
(en)
|
2010-10-08 |
2017-08-08 |
Terumo Bct, Inc. |
Configurable methods and systems of growing and harvesting cells in a hollow fiber bioreactor system
|
US8974451B2
(en)
|
2010-10-25 |
2015-03-10 |
Boston Scientific Scimed, Inc. |
Renal nerve ablation using conductive fluid jet and RF energy
|
US9220558B2
(en)
|
2010-10-27 |
2015-12-29 |
Boston Scientific Scimed, Inc. |
RF renal denervation catheter with multiple independent electrodes
|
US9028485B2
(en)
|
2010-11-15 |
2015-05-12 |
Boston Scientific Scimed, Inc. |
Self-expanding cooling electrode for renal nerve ablation
|
US9668811B2
(en)
|
2010-11-16 |
2017-06-06 |
Boston Scientific Scimed, Inc. |
Minimally invasive access for renal nerve ablation
|
US9089350B2
(en)
|
2010-11-16 |
2015-07-28 |
Boston Scientific Scimed, Inc. |
Renal denervation catheter with RF electrode and integral contrast dye injection arrangement
|
US9326751B2
(en)
|
2010-11-17 |
2016-05-03 |
Boston Scientific Scimed, Inc. |
Catheter guidance of external energy for renal denervation
|
US9060761B2
(en)
|
2010-11-18 |
2015-06-23 |
Boston Scientific Scime, Inc. |
Catheter-focused magnetic field induced renal nerve ablation
|
SG10201509499RA
(en)
|
2010-11-19 |
2015-12-30 |
Eisai R&D Man Co Ltd |
Neutralizing anti-ccl20 antibodies
|
US9023034B2
(en)
|
2010-11-22 |
2015-05-05 |
Boston Scientific Scimed, Inc. |
Renal ablation electrode with force-activatable conduction apparatus
|
US9192435B2
(en)
|
2010-11-22 |
2015-11-24 |
Boston Scientific Scimed, Inc. |
Renal denervation catheter with cooled RF electrode
|
US20120157993A1
(en)
|
2010-12-15 |
2012-06-21 |
Jenson Mark L |
Bipolar Off-Wall Electrode Device for Renal Nerve Ablation
|
US9220561B2
(en)
|
2011-01-19 |
2015-12-29 |
Boston Scientific Scimed, Inc. |
Guide-compatible large-electrode catheter for renal nerve ablation with reduced arterial injury
|
CA2828405A1
(en)
|
2011-02-28 |
2012-09-07 |
Istituto Di Ricovero E Cura A Carattere Scientifico Materno-Infantile Bu Rlo Garofolo - Ospedale Di Alta Specializzazione E Di Rilievo Nazionale |
Apoptosis-inducing molecules and uses therefor
|
CN107115526A
(zh)
|
2011-05-02 |
2017-09-01 |
免疫医疗公司 |
用于小体积施用的同种异型选择的抗体的超滤浓缩
|
JP2014513128A
(ja)
|
2011-05-03 |
2014-05-29 |
ジェネンテック, インコーポレイテッド |
血管破壊剤とその使用
|
AU2012283908B2
(en)
|
2011-07-20 |
2017-02-16 |
Boston Scientific Scimed, Inc. |
Percutaneous devices and methods to visualize, target and ablate nerves
|
WO2013016203A1
(en)
|
2011-07-22 |
2013-01-31 |
Boston Scientific Scimed, Inc. |
Nerve modulation system with a nerve modulation element positionable in a helical guide
|
EP2765942B1
(de)
|
2011-10-10 |
2016-02-24 |
Boston Scientific Scimed, Inc. |
Medizinische vorrichtungen mit ablationselektroden
|
US10085799B2
(en)
|
2011-10-11 |
2018-10-02 |
Boston Scientific Scimed, Inc. |
Off-wall electrode device and methods for nerve modulation
|
US9420955B2
(en)
|
2011-10-11 |
2016-08-23 |
Boston Scientific Scimed, Inc. |
Intravascular temperature monitoring system and method
|
US9364284B2
(en)
|
2011-10-12 |
2016-06-14 |
Boston Scientific Scimed, Inc. |
Method of making an off-wall spacer cage
|
US9079000B2
(en)
|
2011-10-18 |
2015-07-14 |
Boston Scientific Scimed, Inc. |
Integrated crossing balloon catheter
|
EP2768563B1
(de)
|
2011-10-18 |
2016-11-09 |
Boston Scientific Scimed, Inc. |
Biegbare medizinische vorrichtungen
|
EP2775948B1
(de)
|
2011-11-08 |
2018-04-04 |
Boston Scientific Scimed, Inc. |
Ostiale nierennervenablation
|
EP2779929A1
(de)
|
2011-11-15 |
2014-09-24 |
Boston Scientific Scimed, Inc. |
Vorrichtung und verfahren zur überwachung von nierennervenmodulation
|
US9119632B2
(en)
|
2011-11-21 |
2015-09-01 |
Boston Scientific Scimed, Inc. |
Deflectable renal nerve ablation catheter
|
US9265969B2
(en)
|
2011-12-21 |
2016-02-23 |
Cardiac Pacemakers, Inc. |
Methods for modulating cell function
|
WO2013096913A2
(en)
|
2011-12-23 |
2013-06-27 |
Vessix Vascular, Inc. |
Methods and apparatuses for remodeling tissue of or adjacent to a body passage
|
WO2013101452A1
(en)
|
2011-12-28 |
2013-07-04 |
Boston Scientific Scimed, Inc. |
Device and methods for nerve modulation using a novel ablation catheter with polymeric ablative elements
|
US9050106B2
(en)
|
2011-12-29 |
2015-06-09 |
Boston Scientific Scimed, Inc. |
Off-wall electrode device and methods for nerve modulation
|
US20150056204A1
(en)
|
2012-03-28 |
2015-02-26 |
Amgen Inc. |
Dr5 receptor agonist combinations
|
US10660703B2
(en)
|
2012-05-08 |
2020-05-26 |
Boston Scientific Scimed, Inc. |
Renal nerve modulation devices
|
EP2684896A1
(de)
|
2012-07-09 |
2014-01-15 |
International-Drug-Development-Biotech |
Antikörper gegen die DR5-Familie, bispezifische oder multivalente Antikörper gegen die DR5-Familie und Verfahren zu deren Verwendung
|
CA2874864C
(en)
|
2012-08-14 |
2023-02-21 |
Ibc Pharmaceuticals, Inc. |
T-cell redirecting bispecific antibodies for treatment of disease
|
US10321946B2
(en)
|
2012-08-24 |
2019-06-18 |
Boston Scientific Scimed, Inc. |
Renal nerve modulation devices with weeping RF ablation balloons
|
EP2895095A2
(de)
|
2012-09-17 |
2015-07-22 |
Boston Scientific Scimed, Inc. |
Selbstpositionierendes elektrodensystem und verfahren für renale nervenmodulation
|
US10398464B2
(en)
|
2012-09-21 |
2019-09-03 |
Boston Scientific Scimed, Inc. |
System for nerve modulation and innocuous thermal gradient nerve block
|
US10549127B2
(en)
|
2012-09-21 |
2020-02-04 |
Boston Scientific Scimed, Inc. |
Self-cooling ultrasound ablation catheter
|
JP6074051B2
(ja)
|
2012-10-10 |
2017-02-01 |
ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. |
血管内神経変調システム及び医療用デバイス
|
WO2014066700A1
(en)
|
2012-10-25 |
2014-05-01 |
Tocagen Inc. |
Retroviral vector with mini-promoter cassette
|
CA2884313C
(en)
|
2012-12-13 |
2023-01-03 |
Immunomedics, Inc. |
Dosages of immunoconjugates of antibodies and sn-38 for improved efficacy and decreased toxicity
|
WO2014143571A1
(en)
|
2013-03-11 |
2014-09-18 |
Boston Scientific Scimed, Inc. |
Medical devices for modulating nerves
|
US9956033B2
(en)
|
2013-03-11 |
2018-05-01 |
Boston Scientific Scimed, Inc. |
Medical devices for modulating nerves
|
US9808311B2
(en)
|
2013-03-13 |
2017-11-07 |
Boston Scientific Scimed, Inc. |
Deflectable medical devices
|
SI2970473T1
(sl)
|
2013-03-14 |
2017-10-30 |
Bristol-Myers Squibb Company |
Kombinacija dr5 agonista in anti-pd-1 antagonista in postopek uporabe
|
JP6220044B2
(ja)
|
2013-03-15 |
2017-10-25 |
ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. |
腎神経アブレーションのための医療用デバイス
|
US10265122B2
(en)
|
2013-03-15 |
2019-04-23 |
Boston Scientific Scimed, Inc. |
Nerve ablation devices and related methods of use
|
CN105228546B
(zh)
|
2013-03-15 |
2017-11-14 |
波士顿科学国际有限公司 |
利用阻抗补偿的用于治疗高血压的医疗器械和方法
|
US9943365B2
(en)
|
2013-06-21 |
2018-04-17 |
Boston Scientific Scimed, Inc. |
Renal denervation balloon catheter with ride along electrode support
|
JP2016524949A
(ja)
|
2013-06-21 |
2016-08-22 |
ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. |
回転可能シャフトを有する腎神経アブレーション用医療装置
|
US9707036B2
(en)
|
2013-06-25 |
2017-07-18 |
Boston Scientific Scimed, Inc. |
Devices and methods for nerve modulation using localized indifferent electrodes
|
WO2015002787A1
(en)
|
2013-07-01 |
2015-01-08 |
Boston Scientific Scimed, Inc. |
Medical devices for renal nerve ablation
|
US10660698B2
(en)
|
2013-07-11 |
2020-05-26 |
Boston Scientific Scimed, Inc. |
Devices and methods for nerve modulation
|
EP3019106A1
(de)
|
2013-07-11 |
2016-05-18 |
Boston Scientific Scimed, Inc. |
Medizinische vorrichtung mit dehnbaren elektrodenanordnungen
|
EP3049007B1
(de)
|
2013-07-19 |
2019-06-12 |
Boston Scientific Scimed, Inc. |
Nierendenervierungsballon mit spiralförmiger bipolarer elektrode
|
US10695124B2
(en)
|
2013-07-22 |
2020-06-30 |
Boston Scientific Scimed, Inc. |
Renal nerve ablation catheter having twist balloon
|
WO2015013205A1
(en)
|
2013-07-22 |
2015-01-29 |
Boston Scientific Scimed, Inc. |
Medical devices for renal nerve ablation
|
JP6159888B2
(ja)
|
2013-08-22 |
2017-07-05 |
ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. |
腎神経変調バルーンへの接着性を向上させたフレキシブル回路
|
US9895194B2
(en)
|
2013-09-04 |
2018-02-20 |
Boston Scientific Scimed, Inc. |
Radio frequency (RF) balloon catheter having flushing and cooling capability
|
CN105530885B
(zh)
|
2013-09-13 |
2020-09-22 |
波士顿科学国际有限公司 |
具有气相沉积覆盖层的消融球囊
|
US11246654B2
(en)
|
2013-10-14 |
2022-02-15 |
Boston Scientific Scimed, Inc. |
Flexible renal nerve ablation devices and related methods of use and manufacture
|
WO2015057521A1
(en)
|
2013-10-14 |
2015-04-23 |
Boston Scientific Scimed, Inc. |
High resolution cardiac mapping electrode array catheter
|
US9770606B2
(en)
|
2013-10-15 |
2017-09-26 |
Boston Scientific Scimed, Inc. |
Ultrasound ablation catheter with cooling infusion and centering basket
|
EP3057520A1
(de)
|
2013-10-15 |
2016-08-24 |
Boston Scientific Scimed, Inc. |
Ballon für medizinische vorrichtung
|
JP6259099B2
(ja)
|
2013-10-18 |
2018-01-10 |
ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. |
可撓性を備える導電性ワイヤを備えるバルーン・カテーテル、並びに関連する使用および製造方法
|
CN105658163B
(zh)
|
2013-10-25 |
2020-08-18 |
波士顿科学国际有限公司 |
去神经柔性电路中的嵌入式热电偶
|
WO2015073913A1
(en)
|
2013-11-16 |
2015-05-21 |
Terumo Bct, Inc. |
Expanding cells in a bioreactor
|
WO2015103617A1
(en)
|
2014-01-06 |
2015-07-09 |
Boston Scientific Scimed, Inc. |
Tear resistant flex circuit assembly
|
EP3095460A4
(de)
|
2014-01-15 |
2017-08-23 |
Shin Nippon Biomedical Laboratories, Ltd. |
Chirales nukleinsäureadjuvans mit antiallergischer wirkung und antiallergikum
|
US11000679B2
(en)
|
2014-02-04 |
2021-05-11 |
Boston Scientific Scimed, Inc. |
Balloon protection and rewrapping devices and related methods of use
|
EP3102136B1
(de)
|
2014-02-04 |
2018-06-27 |
Boston Scientific Scimed, Inc. |
Alternative platzierung von thermischen sensoren auf bipolarer elektrode
|
MX2016010683A
(es)
|
2014-02-21 |
2017-05-11 |
Ibc Pharmaceuticals Inc |
Terapia para tratar enfermedades mediante la induccion de respuesta inmune de las células que expresan trop-2.
|
CA2935748A1
(en)
|
2014-02-25 |
2015-09-03 |
Immunomedics, Inc. |
Humanized rfb4 anti-cd22 antibody
|
US11299528B2
(en)
|
2014-03-11 |
2022-04-12 |
D&D Pharmatech Inc. |
Long acting TRAIL receptor agonists for treatment of autoimmune diseases
|
WO2015148704A1
(en)
|
2014-03-25 |
2015-10-01 |
Terumo Bct, Inc. |
Passive replacement of media
|
CA2953567C
(en)
|
2014-06-24 |
2023-09-05 |
Immunomedics, Inc. |
Anti-histone therapy for vascular necrosis in severe glomerulonephritis
|
CN106715676A
(zh)
|
2014-09-26 |
2017-05-24 |
泰尔茂比司特公司 |
按计划供养
|
CN106999517A
(zh)
|
2014-10-07 |
2017-08-01 |
免疫医疗公司 |
抗体‑药物缀合物的新辅助剂用途
|
CN107428837A
(zh)
|
2015-04-22 |
2017-12-01 |
免疫医疗公司 |
循环trop‑2阳性癌细胞的分离、检测、诊断和/或鉴定
|
PL3313443T3
(pl)
|
2015-06-25 |
2023-11-06 |
Immunomedics, Inc. |
Łączenie przeciwciał anty-hla-dr lub anty-trop-2 z inhibitorami mikrotubuli, inhibitorami parp, 5 inhibitorami kinazy brutona lub inhibitorami 3-kinazy fosfoinozytydu istotnie poprawia wynik terapeutyczny nowotworu
|
EP3316885B1
(de)
|
2015-07-01 |
2021-06-23 |
Immunomedics, Inc. |
Antikörper-sn-38-immunkonjugate mit einem cl2a-linker
|
WO2017004592A1
(en)
|
2015-07-02 |
2017-01-05 |
Terumo Bct, Inc. |
Cell growth with mechanical stimuli
|
UA126897C2
(uk)
|
2015-12-01 |
2023-02-22 |
Генмаб Б.В. |
Антитіла проти dr5 і способи їх застосування
|
JP6797203B2
(ja)
|
2015-12-17 |
2020-12-09 |
ザ・ジョンズ・ホプキンス・ユニバーシティー |
デスレセプターアゴニストによる全身性硬化症の改善
|
CN109195620B
(zh)
|
2016-04-07 |
2022-06-28 |
约翰霍普金斯大学 |
用死亡受体激动剂治疗胰腺炎和疼痛的组合物和方法
|
US11104874B2
(en)
|
2016-06-07 |
2021-08-31 |
Terumo Bct, Inc. |
Coating a bioreactor
|
US11685883B2
(en)
|
2016-06-07 |
2023-06-27 |
Terumo Bct, Inc. |
Methods and systems for coating a cell growth surface
|
CN106243215B
(zh)
*
|
2016-08-17 |
2019-09-03 |
哈尔滨医科大学 |
一种人trail i型受体激动性抗原表位多肽及其抗体和应用
|
EP3323428A1
(de)
|
2016-11-17 |
2018-05-23 |
CNRS Centre National de la Recherche Scientifique |
Selektive c-flip-hemmer als antikrebsmittel
|
US11624046B2
(en)
|
2017-03-31 |
2023-04-11 |
Terumo Bct, Inc. |
Cell expansion
|
US11702634B2
(en)
|
2017-03-31 |
2023-07-18 |
Terumo Bct, Inc. |
Expanding cells in a bioreactor
|
EP3910331A1
(de)
|
2020-05-15 |
2021-11-17 |
iOmx Therapeutics AG |
Intrazelluläre kinase in verbindung mit resistenz gegen t-zell-vermittelte zytotoxizität und verwendungen davon
|
US11767353B2
(en)
|
2020-06-05 |
2023-09-26 |
Theraly Fibrosis, Inc. |
Trail compositions with reduced immunogenicity
|
EP4342497A1
(de)
|
2021-05-10 |
2024-03-27 |
Kawasaki Institute of Industrial Promotion |
Antikörper mit reduzierter bindungsaffinität für antigen
|
EP4257132A1
(de)
|
2022-04-08 |
2023-10-11 |
iOmx Therapeutics AG |
Sik3-inhibitoren zum behandeln von krankheiten, die gegen death-rezeptor -signaltransduktion resistent sind
|